Effectiveness of early cycles of fast-acting treatment in generalised myasthenia gravis

Abstract

Early cycles of intervention with EFT and early use of calcineurin inhibitors provides long-term benefits in terms of achieving therapeutic targets for generalised MG, regardless of clinical subtype.